Optimal adjuvant chemotherapy in breast cancer : selection of agents
2014-01-01 Esposito, A.; Criscitiello, C.; Omodeo Salè, E.; Curigliano, G.
Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment response
2023-01-01 Bosi, Carlo; Bartha, Áron; Galbardi, Barbara; Notini, Giulia; Naldini, Matteo M; Licata, Luca; Viale, Giulia; Mariani, Marco; Pistilli, Barbara; Ali, H Raza; André, Fabrice; Piras, Marta; Callari, Maurizio; Barreca, Marco; Locatelli, Alberta; Viganò, Lucia; Criscitiello, Carmen; Pusztai, Lajos; Curigliano, Giuseppe; Győrffy, Balázs; Dugo, Matteo; Bianchini, Giampaolo
Benefit of adjuvant chemotherapy in patients with lobular breast cancer : A systematic review of the literature and metanalysis
2021-01-01 Trapani, D; Gandini, S; Corti, C; Crimini, E; Bellerba, F; Minchella, I; Criscitiello, C; Tarantino, P; Curigliano, G
Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial
2013-01-01 Criscitiello, C; Azim Ha, Jr; Agbor-tarh, D; De Azambuja, E; Piccart, M; Baselga, J; Eidtmann, H; Di Cosimo, S; Bradbury, I; Rubio, It
Cardiotoxicity of Agents Used in Patients With Breast Cancer
2024-01-01 Zagami, Paola; Trapani, Dario; Nicolò, Eleonora; Corti, Chiara; Valenza, Carmine; Criscitiello, Carmen; Curigliano, Giuseppe; Carey, Lisa Anne
Tucatinib's journey from clinical development to clinical practice: New horizons for HER2-positive metastatic disease and promising prospects for brain metastatic spread
2023-01-01 Criscitiello, Carmen; Corti, Chiara; De Laurentiis, Michelino; Bianchini, Giampaolo; Pistilli, Barbara; Cinieri, Saverio; Castellan, Lucio; Arpino, Grazia; Conte, Pierfranco; Di Meco, Francesco; Gennari, Alessandra; Guarneri, Valentina; Visani, Luca; Livi, Lorenzo; Marchetti, Paolo; Puglisi, Fabio; Viale, Giuseppe; Del Mastro, Lucia; De Placido, Sabino; Curigliano, Giuseppe
Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers
2016-01-01 Fumagalli, D; Wilson, Tr; Salgado, R; Lu, X; Yu, J; O'Brien, C; Walter, K; Huw, Ly; Criscitiello, C; Laios, I; Jose, V; Brown, Dn; Rothé, F; Maetens, M; Zardavas, D; Savas, P; Larsimont, D; Piccart-Gebhart, Mj; Michiels, S; Lackner, Mr; Sotiriou, C; Loi, S
HER2-Low Breast Cancer: a New Subtype?
2023-01-01 Corti, Chiara; Giugliano, Federica; Nicolò, Eleonora; Tarantino, Paolo; Criscitiello, Carmen; Curigliano, Giuseppe
Tumor-infiltrating lymphocytes (TILs) in ER+/HER2− breast cancer
2020-01-01 Criscitiello, C.; Vingiani, A.; Maisonneuve, P.; Viale, G.; Viale, G.; Curigliano, G.
Novel endocrine therapies: What is next in estrogen receptor positive, HER2 negative breast cancer?
2023-01-01 Corti, Chiara; De Angelis, Carmine; Bianchini, Giampaolo; Malorni, Luca; Giuliano, Mario; Hamilton, Erika; Jeselsohn, Rinath; Jhaveri, Komal; Curigliano, Giuseppe; Criscitiello, Carmen
How I treat HER2-positive early breast cancer: how long adjuvant trastuzumab is needed?
2022-01-01 Morganti, S.; Bianchini, G.; Giordano, A.; Giuliano, M.; Curigliano, G.; Criscitiello, C.
Harmonizing gene signatures to predict benefit from adjuvant chemotherapy in early breast cancer
2019-01-01 Criscitiello, C.; Viale, G.; Curigliano, G.
Immune and Gene-expression Profiling in Estrogen Receptor Low and Negative Early Breast Cancer
2024-01-01 Massa, Davide; Vernieri, Claudio; Nicolè, Lorenzo; Criscitiello, Carmen; Boissière-Michot, Florence; Guiu, Séverine; Bobrie, Angélique; Griguolo, Gaia; Miglietta, Federica; Vingiani, Andrea; Lobefaro, Riccardo; Taurelli Salimbeni, Beatrice; Pinato, Claudia; Schiavi, Francesca; Brich, Silvia; Pescia, Carlo; Fusco, Nicola; Pruneri, Giancarlo; Fassan, Matteo; Curigliano, Giuseppe; Guarneri, Valentina; Jacot, William; Dieci, Maria Vittoria
RNAi screens identify CHD4 as an essential gene in breast cancer growth
2016-01-01 D'Alesio, C.; Punzi, S.; Cicalese, A.; Fornasari, L.; Furia, L.; Riva, L.; Carugo, A.; Curigliano, G.; Criscitiello, C.; Pruneri, G.; Pelicci, P. G.; Faretta, M.; Bossi, D.; Lanfrancone, L.
Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence
2024-01-01 Ivanova, M.; Pescia, C.; Trapani, D.; Venetis, K.; Frascarelli, C.; Mane, E.; Cursano, G.; Sajjadi, E.; Scatena, C.; Cerbelli, B.; D'Amati, G.; Porta, F. M.; Guerini-Rocco, E.; Criscitiello, C.; Curigliano, G.; Fusco, N.
Entinostat for the treatment of breast cancer
2017-01-01 Trapani, ; Esposito, Angela; Criscitiello, Carmen; Carmen;, Mazzarella; Locatelli, Marzia; Minchella, Ida; Ida;, Minucci; Saverio;, Curigliano
Metaplastic breast cancer: an all-round multidisciplinary consensus
2023-01-01 Corso, Giovanni; Criscitiello, Carmen; Nicosia, Luca; Pesapane, Filippo; Vicini, Elisa; Magnoni, Francesca; Sibilio, Andrea; Zanzottera, Cristina; De Scalzi, Alessandra Margherita; Mannucci, Sara; Marabelli, Monica; Calvello, Mariarosaria; Feroce, Irene; Zagami, Paola; Porta, Francesca Maria; Toesca, Antonio; Tarantino, Paolo; Nicolò, Eleonora; Mazzarol, Giovanni; La Vecchia, Carlo; Bonanni, Bernardo; Leonardi, Maria Cristina; Veronesi, Paolo; Fusco, Nicola
Immune approaches to the treatment of breast cancer, around the corner?
2014-01-01 Criscitiello, C.; Esposito, A.; Gelao, L.; Fumagalli, L.; Locatelli, M.; Minchella, I.; Adamoli, L.; Goldhirsch, A.; Curigliano, G.
Managing side effects of immune checkpoint inhibitors in breast cancer
2021-01-01 Criscitiello, Carmen; Corti, Chiara; Pravettoni, Gabriella; Curigliano, Giuseppe
Tumor-associated antigens in breast cancer
2012-01-01 Criscitiello, C
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Optimal adjuvant chemotherapy in breast cancer : selection of agents | 1-gen-2014 | Esposito, A.; Criscitiello, C.; Omodeo Salè, E.; Curigliano, G. | |
| Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment response | 1-gen-2023 | Bosi, Carlo; Bartha, Áron; Galbardi, Barbara; Notini, Giulia; Naldini, Matteo M; Licata, Luca; Viale, Giulia; Mariani, Marco; Pistilli, Barbara; Ali, H Raza; André, Fabrice; Piras, Marta; Callari, Maurizio; Barreca, Marco; Locatelli, Alberta; Viganò, Lucia; Criscitiello, Carmen; Pusztai, Lajos; Curigliano, Giuseppe; Győrffy, Balázs; Dugo, Matteo; Bianchini, Giampaolo | |
| Benefit of adjuvant chemotherapy in patients with lobular breast cancer : A systematic review of the literature and metanalysis | 1-gen-2021 | Trapani, D; Gandini, S; Corti, C; Crimini, E; Bellerba, F; Minchella, I; Criscitiello, C; Tarantino, P; Curigliano, G | |
| Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial | 1-gen-2013 | Criscitiello, C; Azim Ha, Jr; Agbor-tarh, D; De Azambuja, E; Piccart, M; Baselga, J; Eidtmann, H; Di Cosimo, S; Bradbury, I; Rubio, It | |
| Cardiotoxicity of Agents Used in Patients With Breast Cancer | 1-gen-2024 | Zagami, Paola; Trapani, Dario; Nicolò, Eleonora; Corti, Chiara; Valenza, Carmine; Criscitiello, Carmen; Curigliano, Giuseppe; Carey, Lisa Anne | |
| Tucatinib's journey from clinical development to clinical practice: New horizons for HER2-positive metastatic disease and promising prospects for brain metastatic spread | 1-gen-2023 | Criscitiello, Carmen; Corti, Chiara; De Laurentiis, Michelino; Bianchini, Giampaolo; Pistilli, Barbara; Cinieri, Saverio; Castellan, Lucio; Arpino, Grazia; Conte, Pierfranco; Di Meco, Francesco; Gennari, Alessandra; Guarneri, Valentina; Visani, Luca; Livi, Lorenzo; Marchetti, Paolo; Puglisi, Fabio; Viale, Giuseppe; Del Mastro, Lucia; De Placido, Sabino; Curigliano, Giuseppe | |
| Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers | 1-gen-2016 | Fumagalli, D; Wilson, Tr; Salgado, R; Lu, X; Yu, J; O'Brien, C; Walter, K; Huw, Ly; Criscitiello, C; Laios, I; Jose, V; Brown, Dn; Rothé, F; Maetens, M; Zardavas, D; Savas, P; Larsimont, D; Piccart-Gebhart, Mj; Michiels, S; Lackner, Mr; Sotiriou, C; Loi, S | |
| HER2-Low Breast Cancer: a New Subtype? | 1-gen-2023 | Corti, Chiara; Giugliano, Federica; Nicolò, Eleonora; Tarantino, Paolo; Criscitiello, Carmen; Curigliano, Giuseppe | |
| Tumor-infiltrating lymphocytes (TILs) in ER+/HER2− breast cancer | 1-gen-2020 | Criscitiello, C.; Vingiani, A.; Maisonneuve, P.; Viale, G.; Viale, G.; Curigliano, G. | |
| Novel endocrine therapies: What is next in estrogen receptor positive, HER2 negative breast cancer? | 1-gen-2023 | Corti, Chiara; De Angelis, Carmine; Bianchini, Giampaolo; Malorni, Luca; Giuliano, Mario; Hamilton, Erika; Jeselsohn, Rinath; Jhaveri, Komal; Curigliano, Giuseppe; Criscitiello, Carmen | |
| How I treat HER2-positive early breast cancer: how long adjuvant trastuzumab is needed? | 1-gen-2022 | Morganti, S.; Bianchini, G.; Giordano, A.; Giuliano, M.; Curigliano, G.; Criscitiello, C. | |
| Harmonizing gene signatures to predict benefit from adjuvant chemotherapy in early breast cancer | 1-gen-2019 | Criscitiello, C.; Viale, G.; Curigliano, G. | |
| Immune and Gene-expression Profiling in Estrogen Receptor Low and Negative Early Breast Cancer | 1-gen-2024 | Massa, Davide; Vernieri, Claudio; Nicolè, Lorenzo; Criscitiello, Carmen; Boissière-Michot, Florence; Guiu, Séverine; Bobrie, Angélique; Griguolo, Gaia; Miglietta, Federica; Vingiani, Andrea; Lobefaro, Riccardo; Taurelli Salimbeni, Beatrice; Pinato, Claudia; Schiavi, Francesca; Brich, Silvia; Pescia, Carlo; Fusco, Nicola; Pruneri, Giancarlo; Fassan, Matteo; Curigliano, Giuseppe; Guarneri, Valentina; Jacot, William; Dieci, Maria Vittoria | |
| RNAi screens identify CHD4 as an essential gene in breast cancer growth | 1-gen-2016 | D'Alesio, C.; Punzi, S.; Cicalese, A.; Fornasari, L.; Furia, L.; Riva, L.; Carugo, A.; Curigliano, G.; Criscitiello, C.; Pruneri, G.; Pelicci, P. G.; Faretta, M.; Bossi, D.; Lanfrancone, L. | |
| Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence | 1-gen-2024 | Ivanova, M.; Pescia, C.; Trapani, D.; Venetis, K.; Frascarelli, C.; Mane, E.; Cursano, G.; Sajjadi, E.; Scatena, C.; Cerbelli, B.; D'Amati, G.; Porta, F. M.; Guerini-Rocco, E.; Criscitiello, C.; Curigliano, G.; Fusco, N. | |
| Entinostat for the treatment of breast cancer | 1-gen-2017 | Trapani, ; Esposito, Angela; Criscitiello, Carmen; Carmen;, Mazzarella; Locatelli, Marzia; Minchella, Ida; Ida;, Minucci; Saverio;, Curigliano | |
| Metaplastic breast cancer: an all-round multidisciplinary consensus | 1-gen-2023 | Corso, Giovanni; Criscitiello, Carmen; Nicosia, Luca; Pesapane, Filippo; Vicini, Elisa; Magnoni, Francesca; Sibilio, Andrea; Zanzottera, Cristina; De Scalzi, Alessandra Margherita; Mannucci, Sara; Marabelli, Monica; Calvello, Mariarosaria; Feroce, Irene; Zagami, Paola; Porta, Francesca Maria; Toesca, Antonio; Tarantino, Paolo; Nicolò, Eleonora; Mazzarol, Giovanni; La Vecchia, Carlo; Bonanni, Bernardo; Leonardi, Maria Cristina; Veronesi, Paolo; Fusco, Nicola | |
| Immune approaches to the treatment of breast cancer, around the corner? | 1-gen-2014 | Criscitiello, C.; Esposito, A.; Gelao, L.; Fumagalli, L.; Locatelli, M.; Minchella, I.; Adamoli, L.; Goldhirsch, A.; Curigliano, G. | |
| Managing side effects of immune checkpoint inhibitors in breast cancer | 1-gen-2021 | Criscitiello, Carmen; Corti, Chiara; Pravettoni, Gabriella; Curigliano, Giuseppe | |
| Tumor-associated antigens in breast cancer | 1-gen-2012 | Criscitiello, C |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26266
Data di pubblicazione
- In corso di stampa10
- 2020 - 20268444
- 2010 - 201911540
- 2000 - 20094513
- 1990 - 19991428
- 1980 - 1989308
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE358
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...259
- ANNALS OF ONCOLOGY239
- CANCERS223
- THE JOURNAL OF NUCLEAR MEDICINE221
- PLOS ONE211
- EUROPEAN JOURNAL OF CANCER197
- GASTROINTESTINAL ENDOSCOPY193
- ALLERGY178
- JOURNAL OF CLINICAL ONCOLOGY169
Keyword
- Humans2102
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19408
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng18439
- ita405
- spa13
- fre11
- ger8
- enm3
- por2
- chi1
- und1
Accesso al fulltext
- no fulltext24066
- reserved1312
- open888